H.U. Group Holdings, Inc., the Japan-based global healthcare giant with significant operations in India, the USA, and Europe, has announced a landmark leadership transition. Mr. Goki Ishikawa has been appointed as the new Representative Executive Officer and CEO, effective April 1, 2026. This appointment is a strategic cornerstone of the company’s ambitious Medium-Term Management Plan, “H.U. 2030.” Mr. Ishikawa is tasked with accelerating growth in the In Vitro Diagnostics (IVD) market and strengthening the group’s global testing and laboratory services through digital innovation and international expansion.
